Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKitwave Regulatory News (KITW)

  • This share is currently suspended. It was suspended at a price of 294.00
  • There is currently no data for KITW

Form 8.3

28 Jan 2026 12:54

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

GAMCO Investors, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Kitwave Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

January 27, 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Cash-settled derivatives:

882,771

1.05

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

882,771

1.05

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

(GBP)

(b) Cash-settled derivative transactions

Date

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(GBP)

1/27/26

Ordinary

CFD

Increasing long position

225,000

2.94

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

January 28, 2026

Contact name:

David Goldman

Telephone number:

914-921-7793

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’sMarket Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260128807277/en/

Copyright Business Wire 2026

Date   Source Headline
16th Oct 20257:00 amRNSHolding(s) in Company
11th Aug 20257:00 amRNSChange of Accounting Reference Date
18th Jul 202512:03 pmRNSHolding(s) in Company
11th Jul 20254:19 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSInterim Results
10th Jun 20257:00 amRNSNotice of Results
2nd Jun 20257:00 amRNSAppointment of Non-Executive Chair
7th May 20257:00 amRNSTrading Update
9th Apr 20257:00 amRNSDirector/PDMR Shareholdings
28th Mar 202512:13 pmRNSResult of AGM
12th Mar 20257:00 amRNSExercise of Warrants and Total Voting Rights
11th Mar 20252:30 pmRNSDirector/PDMR Shareholding
10th Mar 20257:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSDividend Timetable
5th Mar 20257:00 amRNSNotice of AGM and Publication of Annual Report
4th Mar 20257:30 amRNSManagement Incentive Plan Options Exercised
4th Mar 20257:00 amRNSFinal Results
19th Feb 20259:10 amRNSHolding(s) in Company
18th Feb 20257:00 amRNS-RInvestor Webinar
12th Feb 20257:00 amRNSNotice of Results
7th Nov 20247:00 amRNSTrading Update
11th Oct 202410:30 amRNSDirector/PDMR Shareholding
3rd Oct 20245:00 pmRNSPre-Emption Group Reporting
30th Sep 20245:53 pmRNSHolding(s) in Company
30th Sep 20244:47 pmRNSHolding(s) in Company
30th Sep 20244:42 pmRNSHolding(s) in Company
30th Sep 20244:19 pmRNSHolding(s) in Company
27th Sep 20243:32 pmRNSCompletion of Acquisition
26th Sep 20242:06 pmRNSHolding(s) in Company
25th Sep 20247:00 amRNSResult of Capital Raising
5th Sep 202412:28 pmRNSHolding(s) in Company
3rd Sep 20247:00 amRNSTrading Update
8th Aug 20244:16 pmRNSHolding(s) in Company
8th Jul 20247:00 amRNSHolding(s) in Company
2nd Jul 20242:45 pmRNSDirector/PDMR Shareholding
2nd Jul 20247:00 amRNSInterim Results
25th Jun 20247:00 amRNSHolding(s) in Company
11th Jun 20247:00 amRNSNotice of Results
8th May 20247:00 amRNSHolding(s) in Company
2nd May 20247:00 amRNSTrading Update
17th Apr 20242:51 pmRNSDirector/PDMR Shareholding
3rd Apr 202412:04 pmRNSDirector/PDMR Shareholdings
2nd Apr 20243:01 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSAcquisition of Total Foodservice Solutions Limited
22nd Mar 20241:14 pmRNSResult of AGM and Directorate Change
22nd Mar 202410:16 amRNSHolding(s) in Company
4th Mar 20247:00 amRNSDividend Timetable
1st Mar 20243:42 pmRNSReplacement: Exercise of Warrants & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.